Ludwigia hyssopifolia
Ludwigia hyssopifolia
Ludwigia hyssopifolia is a plant traditionally not associated with any specific medicinal uses in known traditions. However, recent scientific studies have provided insights into its genetic structure and potential biological activities. A study sequenced and characterized the complete chloroplast genomes of three Ludwigia species, including L. hyssopifolia, offering information on their genetic conservation and phylogenetic relationships within the Onagraceae family. Another study found that LH-CUAD (a compound isolated from this plant) induces apoptosis in throat cancer cells through multiple pathways, while certain compounds inhibit human laryngeal cancer cell growth and increase glucose uptake in vitro. The complete chloroplast genome of L. hyssopifolia was also sequenced, revealing a length of 158,938 bp and close genetic relationships with other Ludwigia species. No major safety concerns have been recorded for this plant, nor are there any reported drug interactions. However, the available scientific evidence is limited, so further research would be beneficial to fully understand its potential applications and safety profile.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- This study sequenced and characterized the complete chloroplast genomes of three Ludwigia species, providing insights into their genetic conservation and phylogenetic relationships within the Onagraceae family.
- LH-CUAD induces apoptosis in throat cancer cells via mitochondrial, Akt/mTOR, and endoplasmic reticulum stress pathways.
- Compounds 5 and 8 inhibit human laryngeal cancer cell growth, while compounds 2 and 4 increase glucose uptake in vitro.
- The complete chloroplast genome of L. peruviana was sequenced and found to be 158,938 bp in length, closely related to L. hyssopifolia.
Frequently asked questions
What is Ludwigia hyssopifolia?
Ludwigia hyssopifolia (Ludwigia hyssopifolia) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Ludwigia hyssopifolia?
4 sourced findings are recorded for Ludwigia hyssopifolia; the strongest carries evidence grade D. For example: This study sequenced and characterized the complete chloroplast genomes of three Ludwigia species, providing insights into their genetic conservation and phylogenetic relationships within the Onagraceae family.
How strong is the evidence for Ludwigia hyssopifolia?
The strongest finding for Ludwigia hyssopifolia carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Ludwigia hyssopifolia safe? What are the side effects?
No major safety issues are recorded for Ludwigia hyssopifolia in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Ludwigia hyssopifolia interact with medications?
No drug interactions are recorded for Ludwigia hyssopifolia in our sources. This does not rule them out — check with a pharmacist.
Is Ludwigia hyssopifolia a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 A pair of new isocoumarin enantiomers of Ludwigia hyssopifolia. literature abstract metadata
- T2 A composition of ursolic acid derivatives from Ludwigia hyssopifolia induces apoptosis in throat cancer cells via the Akt/mTOR and mitochondrial signaling pathways and by modulating endoplasmic reticulum stress. literature abstract metadata
- T2 Comparative genomics revealed new insights into the plastome evolution of Ludwigia (Onagraceae, Myrtales). literature abstract metadata
- T2 The complete chloroplast genome sequencing and phylogenetic analysis of Ludwigia peruviana (L.) H.Hara 1953 (Onagraceae). literature abstract metadata